Chemical Lab Reviewer
About the job
- A Bachelor of Science degree in Chemistry or a relevant field is required.
- At least 2 years of experience in pharmaceutical product analysis is required.
- Excellent written and spoken English communication is required.
- Competence with laboratory instrumentation such as high-performance liquid chromatography, gas chromatography, and dissolution testing is required.
- Good skills in Microsoft Office are required.
- Flexibility to work shifts or daytime schedules is required.
- Support complaint investigations, continuous improvement activities, and non-standard testing protocols.
- Complete and maintain required quality records and documents as directed by departmental standard operating procedures, and perform required quality-control review activities.
- Review Batch/Fill Cards for compliance with established specifications.
- Maintain the batch record, including analytical directives and other documents for review.
- Cross-check data against the enterprise resource planning system, master records, and other quality-control databases, including the laboratory information management system.
- Follow all quality management system standard operating procedures, including change controls, deviations, out-of-specification and out-of-trend processes, and other quality-related processes.
- Conduct packaging-material quality-control testing according to standard operating procedures and good manufacturing practices.
- A Master of Science degree in Analytical Chemistry is highly preferred.
- Experience with good manufacturing practices, good laboratory practices, and biopharmaceuticals is preferred.
About the company
Pharmathen develops generic medicines and advanced drug-delivery technologies from its Greece-based manufacturing sites, exporting to branded pharmaceutical companies and patients worldwide. Its products include long-acting injectables, sustained-release formulations, and ophthalmic drugs, built on a strategy of Life Cycle Management and new technology platforms. The company operates with full vertical integration, handling research, development, manufacturing, and export, under facilities approved by the US FDA and EU. This enables it to deliver high-quality generic solutions and optimized dosage forms at scale. Pharmathen differentiates itself through a focused emphasis on drug-delivery platforms, continuous pipeline development, and end-to-end control over development and manufacturing. Its goal is to provide high-quality, affordable medicines while expanding its capabilities in innovative generic products and advanced delivery technologies for global markets.
Company Size
501-1,000
Company Stage
Acquired
Total Funding
N/A
Headquarters
Athens, Greece
Founded
1969
Get referred to Pharmathen
See people who can refer or advise you
Simplify's Take
What believers are saying
- Neuraxpharm's December 2024 alliance creates Europe-wide commercialization for Pharmathen's LAI pipeline.
- CBL Patras acquisition expands peptide capacity and adds an FDA-approved manufacturing base.
- NTC bought Pharmathen's ophthalmology unit, proving monetizable assets despite operational turmoil.
What critics are saying
- FDA issued a 2026 warning letter and import alert over sterile manufacturing failures.
- Reuters reported August 2026 paliperidone shortages from Pharmathen disruptions, hitting schizophrenia patients across Europe.
- Partners Group wrote Pharmathen equity to zero in June 2026, signaling debt-driven distress and possible restructuring.
What makes Pharmathen unique
- Pharmathen pairs drug-delivery R&D with in-house manufacturing across Greece and Europe.
- Its 2024 Neuraxpharm pact locked Pharmathen into psychiatry long-acting injectables globally.
- CBL Patras added FDA-approved peptide manufacturing, strengthening complex sterile capabilities.
Help us improve and share your feedback! Did you find this helpful?
Benefits
- Health Insurance
- Training Programs